Next-Gen Ovarian Cancer Therapy: Nanotechnology-Powered PARP and Immunotherapy
A study titled “Advances in Nanotechnology-Enabled Drug Delivery for Combining PARP Inhibitors and Immunotherapy in Advanced Ovarian Cancer” meticulously explores the utilization of a nanotechnology-enabled drug delivery system to enhance the therapeutic efficacy of combining […]